Stockreport

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

Third Harmonic Bio, Inc.  (THRD) 
PDF U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1 [Read more]